US FDA Grants Expanded Approval of ELEVIDYS Gene Therapy for DMD Patients Ages 4 and Above

Medical Educational Resource

We're accelerating the delivery of treatments and cures.

Time to Re-Evaluate Becker Muscular Dystrophy

Activity Snapshot

Activity Type: 
On-Demand Webinar
Release Date: 
Monday, July 8, 2024
Expiration Date: 
Wednesday, July 2, 2025
Sponsor Information: 

This program is supported in part by an independent medical education grant from Edgewise Therapeutics.

Faculty

Sumit Verma, MD
Associate Professor, Emory University School of Medicine

Pediatric Neurologist, Children’s Healthcare of Atlanta

Activity Overview: 

This webinar will cover the core clinical features and patient-specific phenotypes of BMD, explore the impact of gene-modifying and replacement therapies for related neuromuscular diseases on the BMD treatment landscape, and will explore challenging diagnostic and management scenarios using case examples.

Download Clinician Flashcard

Learning Objectives: 

Recognize symptoms of and use testing modalities to differentially diagnose BMD from other conditions that present similarly.

Review clinical experience guidelines and recommended practices for managing BMD.

Utilize collaboration and communication between healthcare providers from different specialties (e.g., neurology, PT/OT, speech/swallow evaluation, etc.) to ensure coordinated care for patients with BMD.

Incorporate recent advances in clinical studies into patient care and provide guidance to patients on the benefit of and the opportunities for participation in BMD research.

Accreditation and Designation Statement: 

CE credit provided by AKH Inc., Advancing Knowledge in Healthcare.

In support of improving patient care, this activity has been planned and implemented by AKH Inc., Advancing Knowledge in Healthcare and MDA. AKH Inc., Advancing Knowledge in Healthcare is jointly accredited by the Accreditation Council for Continuing Medical Education (ACCME), the Accreditation Council for Pharmacy Education (ACPE), and the American Nurses Credentialing Center (ANCC), to provide continuing education for the healthcare team.

View Full Accreditation and Designation Statements and Disclosure Report Here: https://www.mda.org/sites/default/files/2024/07/Reevaluate-BMD-7-2-2024.pdf

How to Obtain CME credits : 

To obtain a certificate of completion, a score of 70% or better on the post-test is required. Please proceed with the activity until you have successfully completed this program, answered all test questions, completed the post-test and evaluation, and have received a digital copy of your certificate. You must participate in the entire activity to receive credit. There is no fee to participate in this activity. If you have questions about this activity, please contact AKH Inc. at wendi@akhcme.com.

Access CE Evaluation Form Here: https://akhinc.formstack.com/forms/240140me2

Faculty Disclosures: 

None of the planners or faculty for this educational activity have relevant financial relationship(s) to disclose with ineligible companies whose primary business is producing, marketing, selling, re-selling, or distributing healthcare products used by or on patients. All of the relevant financial relationships listed for these individuals have been mitigated.

Name, Relationship, Commercial Interest
_________________________________

Sumit Verma, MD: N/A, Nothing to disclose
Bernadette Makar, MSN, APRN-BC, NP-C (planner/reviewer): N/A, Nothing to disclose
Dorothy Duffy, RPh (planner/reviewer): N/A, Nothing to disclose
Broc Pollinger, MSW, LSW, OSW-C, (planner/reviewer): N/A, Nothing to disclose
AKH Inc Staff and Planners: N/A, Nothing to disclose
MDA Staff and Planners: N/A, Nothing to disclose

Disclosures:
It is the policy of AKH Inc. to ensure independence, balance, objectivity, scientific rigor, and integrity in all of its continuing education activities. The author must disclose to the participants any significant relationships with ineligible companies whose products or devices may be mentioned in the activity or with the commercial supporter of this continuing education activity. Identified conflicts of interest are mitigated by AKH prior to accreditation of the activity. AKH planners and reviewers have no relevant financial relationships to disclose.

Disclosure of Unlabeled Use and Investigational Product:
This educational activity may include discussion of uses of agents that are investigational and/or unapproved by the FDA. Please refer to the official prescribing information for each product for discussion of approved indications, contraindications, and warnings.

Disclaimer:
This course is designed solely to provide the healthcare professional with information to assist in his/her practice and professional development and is not to be considered a diagnostic tool to replace professional advice or treatment. The course serves as a general guide to the healthcare professional, and therefore, cannot be considered as giving legal, nursing, medical, or other professional advice in specific cases. AKH Inc. specifically disclaim responsibility for any adverse consequences resulting directly or indirectly from information in the course, for undetected error, or through participants misunderstanding of the content. If you would like to opt out from future communications from AKH please send an email to optout@akhcme.com with your information with "Opt Out" in the subject line.